Researchers successfully #engineered a chimeric version of the enzyme PikAIII-M5, a key component in #pikromycin biosynthesis, by swapping its beta-ketoreductase domain to control the stereochemistry of macrolide chains.
#Biochemistry #Pharmaceutical #sflorg
https://www.sflorg.com/2026/01/phar01212601.html